Rhythm Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent…
Biotechnology
US, Boston [HQ]

Filings / Resources

Link Index · Filing Reader · 10K/10Q
Loading may take some time.
SEC
2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Transcripts

Gather insights into the latest earnings call through our transcripts.

Other Docs/Resources
Index
Transcripts Investor Relations EDGAR RYTM's Industry Healthcare Analysis Biotechnology Analysis US Analysis Boston Analysis